Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    October 2018
  1. VIDARSDOTTIR H, Tran L, Nodin B, Jirstrom K, et al
    Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Hum Pathol. 2018 Oct 30. pii: S0046-8177(18)30396.
    PubMed     Text format     Abstract available


    September 2018
  2. MACHADO-RUGOLO J, Fabro AT, Ascheri D, Farhat C, et al
    Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting a treatment outcomes of non-small cell lung cancer.
    Hum Pathol. 2018 Sep 12. pii: S0046-8177(18)30352.
    PubMed     Text format     Abstract available


    August 2018
  3. CHEN X, Shao W, Huang H, Feng X, et al
    Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
    Hum Pathol. 2018 Aug 30. pii: S0046-8177(18)30329.
    PubMed     Text format     Abstract available


    June 2018
  4. RAKAEE M, Kilvaer TK, Dalen SM, Richardsen E, et al
    Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Hum Pathol. 2018 Jun 6. pii: S0046-8177(18)30185.
    PubMed     Text format     Abstract available


    February 2018
  5. BOSCH DE, Farjah F, Wood DE, Schmidt RA, et al
    Regional lymph node sampling in lung carcinoma: a single institutional and national database comparison.
    Hum Pathol. 2018 Feb 12. pii: S0046-8177(18)30042.
    PubMed     Text format     Abstract available


  6. HAYASHI T, Takamochi K, Yanai Y, Mitani K, et al
    Non-small cell lung carcinoma with diffuse co-expression of thyroid transcription factor-1 and DeltaNp63/p40.
    Hum Pathol. 2018 Feb 1. pii: S0046-8177(18)30037.
    PubMed     Text format     Abstract available


    October 2017
  7. RIGHI A, Mancini I, Gambarotti M, Picci P, et al
    Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Hum Pathol. 2017;68:128-135.
    PubMed     Text format     Abstract available


  8. YEO MK, Choi SY, Seong IO, Suh KS, et al
    Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Hum Pathol. 2017;68:103-111.
    PubMed     Text format     Abstract available


    September 2017
  9. NELSON ER, Sharma R, Argani P, Cimino-Mathews A, et al
    Utility of Sox10 labeling in metastatic breast carcinomas.
    Hum Pathol. 2017;67:205-210.
    PubMed     Text format     Abstract available


  10. MARCHEVSKY AM, LeStang N, Hiroshima K, Pelosi G, et al
    The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
    Hum Pathol. 2017;67:160-168.
    PubMed     Text format     Abstract available


    August 2017
  11. TANAKA M, Kohashi K, Kushitani K, Yoshida M, et al
    Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions.
    Hum Pathol. 2017;66:177-182.
    PubMed     Text format     Abstract available


  12. FRYDENLUND N, Mahalingam M
    PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies.
    Hum Pathol. 2017;66:13-33.
    PubMed     Text format     Abstract available


  13. MOLINA-ROMERO C, Rangel-Escareno C, Ortega-Gomez A, Alanis-Funes GJ, et al
    Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.
    Hum Pathol. 2017;66:188-199.
    PubMed     Text format     Abstract available


    June 2017
  14. MATSUSHIMA J, Yazawa T, Suzuki M, Takahashi Y, et al
    Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and beta-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
    Hum Pathol. 2017;64:179-185.
    PubMed     Text format     Abstract available


    May 2017
  15. YVOREL V, Forest F, Karpathiou G, Peoc'h M, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung-reply.
    Hum Pathol. 2017;63:220-221.
    PubMed     Text format    


  16. MENGOLI MC, Bettelli S, Gasparri P, Bertolini F, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung.
    Hum Pathol. 2017;63:218-220.
    PubMed     Text format    


    April 2017
  17. KRENCZ I, Sebestyen A, Fabian K, Mark A, et al
    Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma.
    Hum Pathol. 2017;62:66-73.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: